The intracellular distribution of TRAF3IP2-AS1 suggested that TRAF3IP2-AS1 might also have a post-transcriptional regulation function that contributes to NONO-TFE3 tRCC progression. This evidence concerns the gene NONO and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.